Blood pressure variability: Cardiovascular risk integrator or independent risk factor

Journal of Human Hypertension

Volumn 29, Issue 2, 2015, Pages 122-126

  Blacher, J ^a,b   Safar, M E ^a   Ly, C ^a   Szabo De Edelenyi, F ^b   Hercberg, S ^b,c   Galan, P ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b PARIS DESCARTES UNIVERSITY   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYANOCOBALAMIN; FOLIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FRANCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTOR;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84926220827     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.44     Document Type: Article

References (11)

1. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
2. Sander D, Kukla C, Klingelhö fer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000; 102: 1536-1541.
3. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710-714.
4. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B et al. Pronostic significance of visit-to-visit variability, maximal systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
5. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-948.
6. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B et al. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9: 469-480.
7. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population. findings for NHANES III, 1988 to 1994. Hypertension 2011; 57: 160-166.
8. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S et al. Effects of B-vitamins and omega 3 fatty acids on cardiovascular diseases: a randomized placebo-controlled trial. BMJ 2010; 341: c6273.
9. Galan P, Briançon S, Blacher J, Czernichow S, Hercberg S. The SU-FOL-OM3 study. A secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics. Trials 2008; 9: 35.
10. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
11. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906-915.